Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.7 |
mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |